Clinical trial
A Phase I/II Study of Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers
NCT05153304 is registered in ClinicalTrials.gov with University of California, San Diego as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I/II Study of Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers
- Lead sponsor
- University of California, San Diego
- Phase
- Phase 1/2
- Overall status
- Withdrawn
- Start date
- June 30, 2024
- Completion date
- June 30, 2027
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer of gastrointestinal tract